Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017

被引：16

作者：

Shimbashi, Reiko ^{[1
,2
]}

Suzuki, Motoi ^{[1
,2
]}

Chang, Bin ^{[1
]}

Watanabe, Hiroshi ^{[3
]}

Tanabe, Yoshinari ^{[4
]}

Kuronuma, Koji ^{[5
]}

Oshima, Kengo ^{[2
]}

Maruyama, Takaya ^{[6
]}

Takeda, Hiroaki ^{[7
]}

Kasahara, Kei ^{[8
]}

Fujita, Jiro ^{[9
]}

Nishi, Junichiro ^{[10
]}

Kubota, Tetsuya ^{[11
]}

Tanaka-Taya, Keiko ^{[1
]}

Matsui, Tamano ^{[1
]}

Sunagawa, Tomimasa ^{[1
]}

Oishi, Kazunori ^{[1
,12
]}

机构：

[1] Natl Inst Infect Dis, Tokyo, Japan

[2] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan

[3] Kurume Univ, Sch Med, Fukuoka, Japan

[4] Niigata Prefectural Shibata Hosp, Niigata, Japan

[5] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan

[6] Natl Hosp Org Mie Natl Hosp, Tsu, Mie, Japan

[7] Yamagata Saisei Hosp, Yamagata, Japan

[8] Nara Med Univ, Nara, Japan

[9] Univ Ryukyus, Grad Sch Med, Nishihara, Okinawa, Japan

[10] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan

[11] Kochi Univ, Kochi Med Sch, Kochi, Japan

[12] Toyama Inst Hlth, Toyama, Japan

来源：

EMERGING INFECTIOUS DISEASES | 2020年 / 26卷 / 10期

关键词：

PNEUMONIAE SEROTYPE 12F; CONJUGATE VACCINE; POPULATION; IMPACT; OLDER; SPAIN;

D O I：

10.3201/eid2610.191531

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The decline in the proportion of pneumococcal conjugate vaccine (PCV)-covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) because its effectiveness differs according to serotype. Using the indirect cohort method, we calculated the effectiveness of PPSV23 against IPD among adults in Japan to assess the impact of the national pediatric PCV program. Clinical and epidemiologic information and pneumococcal isolates were collected from IPD patients >= 20 years of age through enhanced IPD surveillance during April 2013-December 2017. Adjusted effectiveness against PPSV23-serotype IPD was 42.2%. Despite a substantial decline in the proportion of 13-valent PCV serotypes during the study period (45% to 31%), the change in effectiveness for PPSV23-serotype IPD was limited (47.1% to 39.3%) and only marginal in the elderly population (39.9% to 39.4%). The pediatric PCV program had limited impact on PPSV23 effectiveness against IPD in adults.

引用

页码：2378 / 2386

页数：9

共 41 条

[1] Pneumococcal Capsular Polysaccharide Immunity in the Elderly [J].

Adler, Hugh ;

Ferreira, Daniela M. ;

Gordon, Stephen B. ;

Rylance, Jamie .

CLINICAL AND VACCINE IMMUNOLOGY, 2017, 24 (06)

[2] Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales [J].

Andrews, Nick J. ;

Waight, Pauline A. ;

George, Robert C. ;

Slack, Mary P. E. ;

Miller, Elizabeth .

VACCINE, 2012, 30 (48) :6802-6808

[3] Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults [J].

Bonten, M. J. M. ;

Huijts, S. M. ;

Bolkenbaas, M. ;

Webber, C. ;

Patterson, S. ;

Gault, S. ;

van Werkhoven, C. H. ;

van Deursen, A. M. M. ;

Sanders, E. A. M. ;

Verheij, T. J. M. ;

Patton, M. ;

McDonough, A. ;

Moradoghli-Haftvani, A. ;

Smith, H. ;

Mellelieu, T. ;

Pride, M. W. ;

Crowther, G. ;

Schmoele-Thoma, B. ;

Scott, D. A. ;

Jansen, K. U. ;

Lobatto, R. ;

Oosterman, B. ;

Visser, N. ;

Caspers, E. ;

Smorenburg, A. ;

Emini, E. A. ;

Gruber, W. C. ;

Grobbee, D. E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12) :1114-1125

[4] Immune Dysfunction as a Cause and Consequence of Malnutrition [J].

Bourke, Claire D. ;

Berkley, James A. ;

Prendergast, Andrew J. .

TRENDS IN IMMUNOLOGY, 2016, 37 (06) :386-398

[5] PNEUMOCOCCAL DISEASE AFTER PNEUMOCOCCAL VACCINATION - AN ALTERNATIVE METHOD TO ESTIMATE THE EFFICACY OF PNEUMOCOCCAL VACCINE [J].

BROOME, CV ;

FACKLAM, RR ;

FRASER, DW .

NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (10) :549-552

[6] Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain [J].

Camara, Jordi ;

Maria Marimon, Jose ;

Cercenado, Emilia ;

Larrosa, Nieves ;

Quesada, Maria Dolores ;

Fontanals, Dionisia ;

Cubero, Meritxell ;

Perez-Trallero, Emilio ;

Fenoll, Asuncion ;

Linares, Josefina ;

Ardanuy, Carmen .

PLOS ONE, 2017, 12 (04)

[7] Revisiting Pneumococcal Carriage by Use of Broth Enrichment and PCR Techniques for Enhanced Detection of Carriage and Serotypes [J].

Carvalho, Maria da Gloria ;

Pimenta, Fabiana C. ;

Jackson, Delois ;

Roundtree, Alexis ;

Ahmad, Yusra ;

Millar, Eugene V. ;

O'Brien, Katherine L. ;

Whitney, Cynthia G. ;

Cohen, Adam L. ;

Beall, Bernard W. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) :1611-1618

[8] Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells [J].

Clutterbuck, Elizabeth A. ;

Lazarus, Rajeka ;

Yu, Ly-Mee ;

Bowman, Jaclyn ;

Bateman, Elizabeth A. L. ;

Diggle, Linda ;

Angus, Brian ;

Peto, Tim E. ;

Beverley, Peter C. ;

Mant, David ;

Pollard, Andrew J. .

JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (09) :1408-1416

[9] Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England andWales [J].

Djennad, Abdelmajid ;

Ramsay, Mary E. ;

Pebody, Richard ;

Fry, Norman K. ;

Sheppard, Carmen ;

Ladhani, Shamez N. ;

Andrews, Nick J. .

ECLINICALMEDICINE, 2018, 6 :42-50

[10] Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain:: A case-control study [J].

Domínguez, A ;

Salleras, L ;

Fedson, DS ;

Izquierdo, C ;

Ruíz, L ;

Ciruela, P ;

Fenoll, A ;

Casal, J .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1250-1257

← 1 2 3 4 5 →